SCOPUS 정보 검색 플랫폼

Volumn 20, Issue 1, 2002, Pages 123-127

A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck

(14) Pfister, David G a McCaffrey, John a Zahalsky, Andrew J a Schwartz, Gary K a Lis, Eric a Gerald, William a Huvos, Andrew a Shah, Jatin a Kraus, Dennis a Shaha, Ashok a Singh, Bhuvanesh a Wolden, Suzanne a,b Zelefsky, Michael a,b Palgi, Ilana a

a MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

b Department of Obstetrics Gynecology (United States)

Author keywords

Bryostatin 1; Head and neck cancer

Indexed keywords

BRYOSTATIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE C;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEAD AND NECK CARCINOMA; HUMAN; MALE; METASTASIS; NASOPHARYNX CANCER; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; LACTONES; MACROLIDES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 0036210351 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1023/A:1014449309165 Document Type: Article

Times cited : (23)

References (9)

1
- 0032721005
- Pharmacology and clinical experience with bryostatin 1: A novel anticancer drug
- (1999) Expert Opin Investig Drugs , vol.8 , Issue.12 , pp. 2189-2199
- Philip, P.A.¹ Zonder, J.A.²

2
- 0035233927
- Modulation of protein kinase C in antitumor treatment
- (2001) Rev Physiol Biochem Pharmacol , vol.142 , pp. 1-96
- Hofmann, J.¹

3
- 0027489606
- Phase I study of bryostatin 1: Assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo
- The Cancer Research Campaign Phase I Committee
- (1993) J Natl Cancer Inst , vol.85 , Issue.22 , pp. 1812-1818
- Philip, P.A.¹ Rea, D.² Thavasu, P.³ Carmichael, J.⁴ Stuart, N.S.⁵ Rockett, H.⁶ Talbot, D.C.⁷ Ganesan, T.⁸ Pettit, G.R.⁹ Balkwill, F.¹⁰ Harris, A.L.¹¹

4
- 0031760304
- A phase II study of bryostatin I in metastatic malignant melanoma
- (1998) Br J Cancer , vol.78 , Issue.10 , pp. 1337-1341
- Propper, D.J.¹ Macaulay, V.² O'Byrne, K.J.³ Braybrooke, J.P.⁴ Wilner, S.M.⁵ Ganesan, T.S.⁶ Talbot, D.C.⁷ Harris, A.L.⁸

5
- 0027326957
- A phase I study of intravenous bryostatin I in patients with advanced cancer
- (1993) Br J Cancer , vol.68 , Issue.2 , pp. 418-424
- Prendiville, J.¹ Crowther, D.² Thatcher, N.³ Woll, P.J.⁴ Fox, B.W.⁵ McGown, A.⁶ Testa, N.⁷ Stern, P.⁸ McDermott, R.⁹ Potter, M.¹⁰ Pettit, G.R.¹¹

6
- 0029084804
- A phase I trial of bryostatin I in patients with advanced malignancy using a 24 hour intravenous infusion
- (1995) Br J Cancer , vol.72 , Issue.2 , pp. 461-468
- Jayson, G.C.¹ Crowther, D.² Prendiville, J.³ McGown, A.T.⁴ Scheid, C.⁵ Stern, P.⁶ Young, R.⁷ Brenchley, P.⁸ Chang, J.⁹ Owens, S.¹⁰ Pettit, G.R.¹¹

7
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.² Staquet, M.³ Winkler, A.⁴

8
- 0024536437
- Optimal two-stage designs for phase II clinical trials
- (1989) Control Clin Trials , vol.10 , Issue.1 , pp. 1-10
- Simon, R.¹

9
- 0034006706
- The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow
- (2000) Clinical Cancer Res , vol.6 , Issue.4 , pp. 1498-1507
- Koutcher, J.A.¹ Motwani, M.² Zakian, K.L.³ Li, X.K.⁴ Matei, C.⁵ Dyke, J.P.⁶ Ballon, D.⁷ Yoo, H.H.⁸ Schwartz, G.K.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.